Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 6, 2016, Pages 1100-1105

  Hashad, Doaa ^a   Elbanna, Amany ^b   Ibrahim, Abeer ^b   Khedr, Gihan ^c  

^a Clinical Pathology Department   (Egypt)

^b Preventive Medicine Department   (Egypt)

^c Clinical Oncology Department   (Egypt)

Author keywords

LncRNA H19 gastric cancer biomarker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; LONG UNTRANSLATED RNA; RNA H19; H19 LONG NON-CODING RNA;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; H19 GENE; HUMAN; MALE; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; UPREGULATION; BLOOD; CASE CONTROL STUDY; GENETIC SCREENING; GENETICS; LIVER FUNCTION TEST; MIDDLE AGED; REGRESSION ANALYSIS; STOMACH TUMOR;

ADULT; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; FEMALE; GENETIC TESTING; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RNA, LONG NONCODING; ROC CURVE; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84971350754     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21987     Document Type: Article

References (31)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69.
2. Wu C, Hsiung C, Lo S, et al. Nodal dissection for patients with gastric cancer: A randomised controlled trial. Lancet Oncol 2006;7:309–315.
3. Dassen A, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands. Eur J Cancer 2010;46:1101–1110.
4. Malone C, Hannon G. Small RNAs as Guardians of the Genome. Cell 2009;136:656–668.
5. Plath K, Fang J, Mlynarczyk-Evans SK, et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003;300:131–135.
6. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775–1789.
7. Gabory A, Jammes H, Dandolo L. The H19 locus: Role of an imprinted non-coding RNA in growth and development. BioEssays 2010;32:473–480.
8. Brannan C, Dees E, Ingram R, Tilghman S. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990;10:28–36.
9. Fellig Y, Ariel I, Ohana P, et al. H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol 2005;58:1064–1068.
10. Tabano S, Colapietro P, Cetin I, et al. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics 2010;5:313–324.
11. Matouk IJ, DeGroot N, Mezan S, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007;2:e845.
12. Edge S, Byrd D, Compton C, et al. 2010. AJCC cancer staging manuel, 7th edn. New York: Springer.
13. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31–49.
14. Xie H, Ma H, Zhou D. Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma. Biomed Res Int 2013;2013:136106.
15. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011;12:861–874.
16. Hajjari M, Behmanesh M, Sadeghizadeh M, Zeinoddini M. Junctional adhesion molecules 2 and 3 may potentially be involved in progression of gastric adenocarcinoma tumors. Med Oncol 2013;30:380.
17. Wu H, Lin W, Tsai K. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med 2014;16:1–18.
18. Li Y, Yang Y, Lu M, Shen L. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology 2011;58:2166–2170.
19. DeBaun M, Niemitz E, McNeil D, Brandenburg S, Lee M, Feinberg A. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 2002;70:604–611.
20. Oliva J, Bardag-Gorce F, French BA, Li J, French SW. The regulation of non-coding RNA expression in the liver of mice fed DDC. Exp Mol Pathol 2009;87:12–19.
21. Hajjari M, Khoshnevisan A. Potential long non coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer. Front Genet 2013;4:1–3.
22. Lim D, Maher E. Genomic imprinting syndromes and cancer. Adv Genet 2010;70:145–175.
23. Yang F, Bi J, Xue X, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS 2012;279:3159–3165.
24. Matouk IJ, DeGroot N, Mezan S, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007;2:e84.
25. Song H, Sun W, Ye G, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med 2013;11:225.
26. Arita T, Ichikawa D, Konishi H, et al. Circulating Long Non-coding RNAs in Plasma of Patients with Gastric Cancer. Anticancer Res 2013;33:3185–3194.
27. Cho S, Chang Y, Chang C. MALAT1 long non coding RNA is over expressed in multiple myeloma and may serve as a marker to predict disese progressiom. BMC Cancer 2014;14:809.
28. Kogo R, Shimamura T, Mimori K, et al. Long non coding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011;71:6320–6326.
29. Gupta R, Shah N, Wang K, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010;46:1071–1076.
30. Yang Z, Zhou L, Wu L, et al. Over expression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011;18:1243–1250.
31. Li H, Yu B, Jianfang L, et al. Over-expression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 2014;5:2318–2329.